Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

Diagnosed with COVID-19?

What is the OakTree Study?

If you have been recently diagnosed with COVID-19, you may be interested in the OakTree Study. This clinical research study is
testing the effectiveness and safety of an investigational medication for COVID-19 called GS-5245. Researchers want to see if GS-5245
can shorten the length of time you have symptoms.

To be considered for the study, you must:

  • Be 12 to 64 years of age.
  • Have tested positive for COVID-19 in the past 3 days.
  • Have had COVID-19 symptoms for no more than 3 days.
  • NOT be at risk for developing serious disease.
  • NOT be currently hospitalized or require hospitalization.

Both vaccinated and unvaccinated people will be considered for this study. If you had a vaccine or booster, you must have received it more than 4 months before starting the study.

See if you qualify.

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

Study Locations

Accel Research Sites | Lake Oconee
119 Harmony Crossing
Eatonton, Georgia 31024
Accel Research Sites | St. Petersburg-Largo
8250 Bryan Dairy Road
Largo, Florida 33777